Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3.
Diabetes therapy : research, treatment and education of diabetes and related disorders（2023）
摘要
NCT03987919; NCT03882970.
更多查看译文
关键词
Body weight loss,GIP,GLP-1,Glycaemic control,Insulin degludec,Semaglutide 1 mg,Tirzepatide,Type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要